These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 23100082)
1. The evaluation of ozone and betahistine in the treatment of tinnitus. Sönmez O; Külahlı I; Vural A; Sahin MI; Aydın M Eur Arch Otorhinolaryngol; 2013 Jul; 270(7):1999-2006. PubMed ID: 23100082 [TBL] [Abstract][Full Text] [Related]
2. The effectiveness of transmeatal low-power laser stimulation in treating tinnitus. Ngao CF; Tan TS; Narayanan P; Raman R Eur Arch Otorhinolaryngol; 2014 May; 271(5):975-80. PubMed ID: 23605244 [TBL] [Abstract][Full Text] [Related]
3. A triple blind, placebo controlled, randomised controlled trial of betahistine dihydrochloride in the treatment of primary tinnitus. Castilho GL; Dias NH; Martins RHG Clin Otolaryngol; 2023 Jan; 48(1):50-57. PubMed ID: 36320174 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the combined hearing and masking devices on the severity and perception of tinnitus: a randomized, controlled, double-blind study. Oz I; Arslan F; Hizal E; Erbek SH; Eryaman E; Senkal OA; Ogurlu T; Kizildag AE; Ozluoglu LN ORL J Otorhinolaryngol Relat Spec; 2013; 75(4):211-20. PubMed ID: 23899886 [TBL] [Abstract][Full Text] [Related]
5. Betahistine in the treatment of tinnitus in patients with vestibular disorders. Ganança MM; Caovilla HH; Gazzola JM; Ganança CF; Ganança FF Braz J Otorhinolaryngol; 2011; 77(4):499-503. PubMed ID: 21860977 [TBL] [Abstract][Full Text] [Related]
6. Intratympanic dexamethasone versus high dosage of betahistine in the treatment of intractable unilateral Meniere disease. Albu S; Chirtes F; Trombitas V; Nagy A; Marceanu L; Babighian G; Trabalzini F Am J Otolaryngol; 2015; 36(2):205-9. PubMed ID: 25510210 [TBL] [Abstract][Full Text] [Related]
7. Does betahistine treatment have additional benefits to vestibular rehabilitation? Karapolat H; Celebisoy N; Kirazli Y; Bilgen C; Eyigor S; Gode S; Akyuz A; Kirazli T Eur Arch Otorhinolaryngol; 2010 Aug; 267(8):1207-12. PubMed ID: 20567979 [TBL] [Abstract][Full Text] [Related]
8. Tinnitus therapy using tailor-made notched music delivered via a smartphone application and Ginko combined treatment: A pilot study. Kim SY; Chang MY; Hong M; Yoo SG; Oh D; Park MK Auris Nasus Larynx; 2017 Oct; 44(5):528-533. PubMed ID: 27979609 [TBL] [Abstract][Full Text] [Related]
9. Working Memory, Sleep, and Hearing Problems in Patients with Tinnitus and Hearing Loss Fitted with Hearing Aids. Zarenoe R; Hällgren M; Andersson G; Ledin T J Am Acad Audiol; 2017 Feb; 28(2):141-151. PubMed ID: 28240981 [TBL] [Abstract][Full Text] [Related]
10. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease. Ganança MM; Caovilla HH; Ganança FF Acta Otolaryngol; 2009 May; 129(5):487-92. PubMed ID: 18615332 [TBL] [Abstract][Full Text] [Related]
11. A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Betahistine to Counteract Olanzapine-Associated Weight Gain. Barak N; Beck Y; Albeck JH J Clin Psychopharmacol; 2016 Jun; 36(3):253-6. PubMed ID: 27028981 [TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy of different treatment methods in the treatment of idiopathic tinnitus. Beriat GK; Ezerarslan H; Akmansu SH; Aksoy S; Ay S; Doğan SK; Evcik D; Kocatürk S Kulak Burun Bogaz Ihtis Derg; 2011; 21(3):145-53. PubMed ID: 21595618 [TBL] [Abstract][Full Text] [Related]
13. Dose- and duration-dependent effects of betahistine dihydrochloride treatment on histamine turnover in the cat. Tighilet B; Trottier S; Lacour M Eur J Pharmacol; 2005 Oct; 523(1-3):54-63. PubMed ID: 16226741 [TBL] [Abstract][Full Text] [Related]
14. Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combination. Poyurovsky M; Fuchs C; Pashinian A; Levi A; Weizman R; Weizman A Psychopharmacology (Berl); 2013 Apr; 226(3):615-22. PubMed ID: 23239133 [TBL] [Abstract][Full Text] [Related]
15. [A double-blind randomized controlled trial on the efficacy of mixed pure tone sound therapy in chronic tinnitus patients with different hearing loss]. Li Y; Feng GD; Wu HY; Gao ZQ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 May; 54(5):355-361. PubMed ID: 31137095 [No Abstract] [Full Text] [Related]
16. Oral chemotherapy in tinnitus. Kay NJ Br J Audiol; 1981 May; 15(2):123-4. PubMed ID: 7225648 [TBL] [Abstract][Full Text] [Related]
17. [Betaserc and improvement of life quality in war veterans]. Larikova TI; Cherevikova GM Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(3):68-70. PubMed ID: 15822746 [No Abstract] [Full Text] [Related]
18. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study. Novotný M; Kostrica R Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of repetitive transcranial magnetic stimulation for the treatment of refractory chronic tinnitus: a randomized, placebo controlled study. Anders M; Dvorakova J; Rathova L; Havrankova P; Pelcova P; Vaneckova M; Jech R; Holcat M; Seidl Z; Raboch J Neuro Endocrinol Lett; 2010; 31(2):238-49. PubMed ID: 20424590 [TBL] [Abstract][Full Text] [Related]
20. Estimation of factors influencing the results of tinnitus retraining therapy. Koizumi T; Nishimura T; Sakaguchi T; Okamoto M; Hosoi H Acta Otolaryngol Suppl; 2009 Jun; (562):40-5. PubMed ID: 19848238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]